180 related articles for article (PubMed ID: 17203172)
1. Expression of protease activated receptor-2 related to angiogenesis in tumor advancement of uterine endometrial cancers.
Jahan I; Fujimoto J; Alam SM; Sato E; Sakaguchi H; Tamaya T
Oncol Rep; 2007 Feb; 17(2):345-50. PubMed ID: 17203172
[TBL] [Abstract][Full Text] [Related]
2. Expression of basic fibroblast growth factor and its mRNA in uterine endometrial cancers.
Fujimoto J; Hori M; Ichigo S; Tamaya T
Invasion Metastasis; 1995; 15(5-6):203-10. PubMed ID: 8765195
[TBL] [Abstract][Full Text] [Related]
3. Plausible linkage of hypoxia-inducible factor (HIF) in uterine endometrial cancers.
Fujimoto J; Sato E; Alam SM; Jahan I; Toyoki H; Hong BL; Sakaguchi H; Tamaya T
Oncology; 2006; 71(1-2):95-101. PubMed ID: 17341889
[TBL] [Abstract][Full Text] [Related]
4. Role of protease activated receptor-2 in lymph node metastasis of uterine cervical cancers.
Jahan I; Fujimoto J; Alam SM; Sato E; Tamaya T
BMC Cancer; 2008 Oct; 8():301. PubMed ID: 18937843
[TBL] [Abstract][Full Text] [Related]
5. Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers.
Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
Gynecol Oncol; 2009 Jul; 114(1):84-8. PubMed ID: 19356789
[TBL] [Abstract][Full Text] [Related]
6. Expression of interferon-gamma-inducible protein 10 related to angiogenesis in uterine endometrial cancers.
Sato E; Fujimoto J; Tamaya T
Oncology; 2007; 73(3-4):246-51. PubMed ID: 18424889
[TBL] [Abstract][Full Text] [Related]
7. Oestrogen regulated gene expression in normal and malignant endometrial tissue.
O'Toole SA; Dunn E; Sheppard BL; Sheils O; O'Leary JJ; Wuttke W; Seidlova-Wuttke D
Maturitas; 2005 Jun; 51(2):187-98. PubMed ID: 15917160
[TBL] [Abstract][Full Text] [Related]
8. FGF2 transcript levels are positively correlated with EGF and IGF-1 in the malignant endometrium.
Soufla G; Sifakis S; Spandidos DA
Cancer Lett; 2008 Feb; 259(2):146-55. PubMed ID: 18006148
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of tumor angiogenesis and thymidine phosphorylase tissue expression in patients with endometrial cancer.
Mazurek A; Kuc P; Terlikowski S; Laudanski T
Neoplasma; 2006; 53(3):242-6. PubMed ID: 16652195
[TBL] [Abstract][Full Text] [Related]
10. [Expression of receptor-binding cancer antigen expressed on SiSo cells in endometrial carcinoma and the correlation thereof with the expression of estrogen receptor subtypes].
Zhou XH; Xu ST; Song WY; Teng XD
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(27):1900-3. PubMed ID: 17923013
[TBL] [Abstract][Full Text] [Related]
11. [Expression of pituitary tumor-transforming gene in endometrial carcinoma].
Wang YK; Cui N; Li J; Luo B
Zhonghua Fu Chan Ke Za Zhi; 2004 Aug; 39(8):538-42. PubMed ID: 15363353
[TBL] [Abstract][Full Text] [Related]
12. The pattern of Protease Activated Receptor 1 (PAR1) expression in endometrial carcinoma.
Granovsky-Grisaru S; Zaidoun S; Grisaru D; Yekel Y; Prus D; Beller U; Bar-Shavit R
Gynecol Oncol; 2006 Dec; 103(3):802-6. PubMed ID: 16875721
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor (AR) expression in normal and cancerous human endometrial tissues detected by RT-PCR and immunohistochemistry.
Brys M; Semczuk A; Baranowski W; Jakowicki J; Krajewska WM
Anticancer Res; 2002; 22(2A):1025-31. PubMed ID: 12014620
[TBL] [Abstract][Full Text] [Related]
14. Expression patterns of hyaluronan, hyaluronan synthases and hyaluronidases indicate a role for hyaluronan in the progression of endometrial cancer.
Paiva P; Van Damme MP; Tellbach M; Jones RL; Jobling T; Salamonsen LA
Gynecol Oncol; 2005 Aug; 98(2):193-202. PubMed ID: 15936804
[TBL] [Abstract][Full Text] [Related]
15. Sex steroid-dependent angiogenesis in uterine endometrial cancers.
Fujimoto J; Toyoki H; Jahan I; Alam SM; Sakaguchi H; Sato E; Tamaya T
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):161-5. PubMed ID: 15860258
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor gamma and growth inhibition by its ligands in uterine endometrial carcinoma.
Ota K; Ito K; Suzuki T; Saito S; Tamura M; Hayashi S; Okamura K; Sasano H; Yaegashi N
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4200-8. PubMed ID: 16857792
[TBL] [Abstract][Full Text] [Related]
17. Expression of maspin in endometrioid adenocarcinoma of endometrium.
Li HW; Leung SW; Chan CS; Yu MM; Wong YF
Oncol Rep; 2007 Feb; 17(2):393-8. PubMed ID: 17203179
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of ephrinB2 and EphB4 in tumor advancement of uterine endometrial cancers.
Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
Ann Oncol; 2007 Mar; 18(3):485-90. PubMed ID: 17108150
[TBL] [Abstract][Full Text] [Related]
19. Expressions of vascular endothelial growth factor (VEGF) and its mRNA in uterine endometrial cancers.
Fujimoto J; Ichigo S; Hirose R; Sakaguchi H; Tamaya T
Cancer Lett; 1998 Dec; 134(1):15-22. PubMed ID: 10381125
[TBL] [Abstract][Full Text] [Related]
20. Dysregulated expression of CD66a (BGP, C-CAM), an adhesion molecule of the CEA family, in endometrial cancer.
Bamberger AM; Riethdorf L; Nollau P; Naumann M; Erdmann I; Götze J; Brümmer J; Schulte HM; Wagener C; Löning T
Am J Pathol; 1998 Jun; 152(6):1401-6. PubMed ID: 9626043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
